Authors:
IIZUKA Y
SANADA M
TSUNETOSHI J
YAMAUCHI N
ARAI S
Citation: Y. Iizuka et al., O-18 TRACER STUDIES OF CO OXIDATION WITH O2 ON MOO3 .3. REACTION-MECHANISM OF OXYGEN-ISOTOPE EXCHANGE BETWEEN CO2 AND MOO3, Journal of the Chemical Society. Faraday transactions, 90(22), 1994, pp. 3449-3453
Authors:
KINOSHITA T
KAKIUCHI T
TAKIZAWA A
TSUJITA Y
OYA M
IIZUKA Y
IWATSUKI M
Citation: T. Kinoshita et al., SOLUTE PERMEABILITY ENHANCEMENT AT A SPECIFIC PH BY AN AMPHIPHILIC COPOLYPEPTIDE MEMBRANE, Macromolecules, 27(6), 1994, pp. 1389-1394
Authors:
SAKURAI E
GUNJI E
IIZUKA Y
HIKICHI N
MAEYAMA K
WATANABE T
Citation: E. Sakurai et al., THE DISPOSITION OF THIOPERAMIDE, A HISTAMINE H-3 RECEPTOR ANTAGONIST,IN RATS, Journal of Pharmacy and Pharmacology, 46(3), 1994, pp. 209-212
Authors:
NISHIMURA Y
SATOH T
KONDO S
TAKEUCHI T
AZETAKA M
FUKUYASU H
IIZUKA Y
SHIBAHARA S
Citation: Y. Nishimura et al., EFFECT ON SPONTANEOUS METASTASIS OF MOUSE LEWIS LUNG-CARCINOMA BY A TRIFLUOROACETAMIDE ANALOG OF SIASTATIN-B, Journal of antibiotics, 47(7), 1994, pp. 840-842
Authors:
OKADA M
IIZUKA Y
OH K
MURAYAMA H
MAEKAWA T
Citation: M. Okada et al., GASTRITIS CYSTICA PROFUNDA PRESENTING AS GIANT GASTRIC-MUCOSAL FOLDS - THE ROLE OF ENDOSCOPIC ULTRASONOGRAPHY AND MUCOSECTOMY IN THE DIAGNOSTIC WORK-UP, Gastrointestinal endoscopy, 40(5), 1994, pp. 640-644
Authors:
FUJIBAYASHI K
SAKAMOTO K
WATANABE M
IIZUKA Y
Citation: K. Fujibayashi et al., PHARMACOLOGICAL PROPERTIES OF R-84760, A NOVEL KAPPA-OPIOID RECEPTOR AGONIST, European journal of pharmacology, 261(1-2), 1994, pp. 133-140
Authors:
SAKURAI E
GUNJI E
IIZUKA Y
HIKICHI N
MAEYAMA K
WATANABE T
Citation: E. Sakurai et al., INVIVO MICRODIALYSIS MEASUREMENT OF HISTAMINE IN RAT-BLOOD EFFECTS OFCOMPOUND-48 80 AND HISTAMINE-RECEPTOR ANTAGONISTS/, Journal of pharmacological and toxicological methods, 29(2), 1993, pp. 105-109
Citation: Y. Iizuka et al., KINETIC COMPARISON OF FUNGAL BETA-XYLOSID ASES IN THE CONDENSATION REACTION OF XYLOSE, Seibutsu kogaku kaishi, 71(5), 1993, pp. 325-331
Citation: Y. Iizuka et al., A NEW ASSAY-METHOD FOR XYLOBIOSE-HYDROLYSIS ACTIVITY OF BETA-XYLOSIDASE AND COMPARISON OF SEVERAL BETA-XYLOSIDASES, Bioscience, biotechnology, and biochemistry, 57(4), 1993, pp. 674-675
Authors:
OSHIMI K
YAMADA O
KANEKO T
NISHINARITA S
IIZUKA Y
URABE A
INAMORI T
ASANO S
TAKAHASHI S
HATTORI M
NAOHARA T
OHIRA Y
TOGAWA A
MASUDA Y
OKUBO Y
FURUSAWA S
SAKAMOTO S
OMINE M
MORI M
TATSUMI E
MIZOGUCHI H
Citation: K. Oshimi et al., LABORATORY FINDINGS AND CLINICAL COURSES OF 33 PATIENTS WITH GRANULARLYMPHOCYTE-PROLIFERATIVE DISORDERS, Leukemia, 7(6), 1993, pp. 782-788
Citation: T. Hayashi et al., BIODEGRADATION OF RANDOM COPOLYPEPTIDE MEMBRANES CONSISTING OF N-HYDROXYALKYL L-GLUTAMINE AS ONE-COMPONENT, Biomaterials, 14(7), 1993, pp. 497-502
Citation: T. Hayashi et al., SYNTHESIS AND PROPERTIES OF CHARGED COPOLYPEPTIDES MEMBRANES AS BIODEGRADABLE MATERIALS, Polymer Journal, 25(5), 1993, pp. 481-488
Authors:
ITOH K
MUKAIYAMA O
SATOH Y
YAMAGUCHI T
IIZUKA Y
Citation: K. Itoh et al., EFFECTS OF CS-518, A THROMBOXANE SYNTHASE INHIBITOR, ON EOSINOPHIL FUNCTION, European journal of pharmacology, 239(1-3), 1993, pp. 159-169
Authors:
YAMAGUCHI T
MUKAIYAMA O
ITOH K
SATOH Y
TERADA A
IIZUKA Y
Citation: T. Yamaguchi et al., EFFECTS OF CS-518, A THROMBOXANE SYNTHASE INHIBITOR, ON THE ASTHMATICRESPONSE, European journal of pharmacology, 236(1), 1993, pp. 43-50
Authors:
WATANABE K
IIDA M
TAKAISHI K
SUZUKI T
HAMADA Y
IIZUKA Y
TSURUFUJI S
Citation: K. Watanabe et al., CHEMOATTRACTANTS FOR NEUTROPHILS IN LIPOPOLYSACCHARIDE-INDUCED INFLAMMATORY EXUDATE FROM RATS ARE NOT INTERLEUKIN-8 COUNTERPARTS BUT GRO-GENE-PRODUCT MELANOMA-GROWTH-STIMULATING-ACTIVITY-RELATED FACTORS, European journal of biochemistry, 214(1), 1993, pp. 267-270
Citation: Y. Iizuka et al., SYNTHESIS AND PROPERTIES OF HIGH-MOLECULAR-WEIGHT POLYPEPTIDES CONTAINING PROLINE, Bulletin of the Chemical Society of Japan, 66(4), 1993, pp. 1269-1272
Authors:
AISO M
IIZUKA Y
KANG HI
SAWADA S
OHSHIMA T
HORIE T
Citation: M. Aiso et al., THE MONOCYTE TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION IN PATIENTS WITH ACUTE-LEUKEMIA IN COMPLETE REMISSION, Medical oncology and tumor pharmacotherapy, 9(4), 1992, pp. 191-197